News

Discovered and developed by Eisai, lenvatinib is an oral multiple receptor tyrosine kinase inhibitor with a unique binding mode that selectively inhibits the kinase activities of vascular endothelial

Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), is one of five approved Breckenridge ANDA products secured from the September 2013 acquisition of certain product assets from Cypress Pharmaceutical.

According to the company, TapouT Turbo Blend has generated immediate sales and it differentiates itself from the competition with several innovations such as an organic sourced-whey blend, gluten-free,

Robert Brown, managing director of Encore Consumer Capital, said, "Isopure’s founder Hal Katz decided to bring on a strategic and financial partner in 2007, and Encore was well

Modeled after breath freshening strips already well-known to most consumers, the MacuStrip will deliver exact doses of medical-grade vitamins in the simplest manner possible. The MacuStrip is slated

"Our goal is to help MissionPoint members improve their health status," said Jason Dinger, CEO of MissionPoint Health Partners. "In our experience with managing the health of populations,

An official from WHO noted that the death rate due to this deadly disease has now increased to 70%. The death toll from the Ebola virus outbreak has

Vaxart’s founder and chief scientific officer, Sean Tucker, PhD, discussed the data in a presentation today at the 15th Annual World Vaccine Congress in Brussels. "A tablet vaccine

"We are very excited having selected PPD, one of the world’s leading contract research organizations, to be our strategic clinical development partner in advancing our assets through the